Knight Therapeutics (KHTRF) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.1
-0.04
0.02
0.08

Details

Expected EPS
-0.005135136
Actual EPS
-0.02872
Surprise EPS
-0.02
Surprise Percent
+459.28%

Description

Knight Therapeutics (KHTRF) has reported earnings of -0.02872 per share for Q4 2025.

0 Comments

Share your thoughts